These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35865943)

  • 1. Implementation of
    Tiwattanon K; John S; Koomdee N; Jinda P; Rachanakul J; Jantararoungtong T; Nuntharadthanaphong N; Kloypan C; Biswas M; Boongird A; Sukasem C
    Front Pharmacol; 2022; 13():867490. PubMed ID: 35865943
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.
    Chen CB; Hsiao YH; Wu T; Hsih MS; Tassaneeyakul W; Jorns TP; Sukasem C; Hsu CN; Su SC; Chang WC; Hui RC; Chu CY; Chen YJ; Wu CY; Hsu CK; Chiu TM; Sun PL; Lee HE; Yang CY; Kao PH; Yang CH; Ho HC; Lin JY; Chang YC; Chen MJ; Lu CW; Ng CY; Kuo KL; Lin CY; Yang CS; Chen DP; Chang PY; Wu TL; Lin YJ; Weng YC; Kuo TT; Hung SI; Chung WH;
    Neurology; 2017 Jan; 88(1):78-86. PubMed ID: 27913699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: incidence, features, risk factors and relation to HLA-B alleles.
    He N; Min FL; Shi YW; Guo J; Liu XR; Li BM; Zhou JH; Ou YM; Liao JX; Liao WP
    Seizure; 2012 Oct; 21(8):614-8. PubMed ID: 22818943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption.
    Moon J; Kim TJ; Lim JA; Sunwoo JS; Byun JI; Lee ST; Jung KH; Park KI; Jung KY; Jeon D; Yu KS; Jang IJ; Chu K; Lee SK
    Epilepsia; 2016 Nov; 57(11):1879-1886. PubMed ID: 27666425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between HLA genotypes and Oxcarbazepine-induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-Analysis.
    Tangamornsuksan W; Scholfield N; Lohitnavy M
    J Pharm Pharm Sci; 2018; 21(1):1-18. PubMed ID: 29370880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital.
    Lee JE; Min KR; Kim SH; Kim AH; Kim ST
    Yonsei Med J; 2020 Oct; 61(10):875-879. PubMed ID: 32975062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact on carbamazepine usage and cutaneous adverse reactions before and after the reimbursement of HLA-B*1502 genotyping in Taiwan, 2000-2017: A nationwide longitudinal study.
    Chang BL; Liu JR; Chang SH; See LC
    Epilepsia; 2023 Oct; 64(10):2679-2689. PubMed ID: 37506179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between HLA-A*3201 allele and oxcarbazepine-induced cutaneous adverse reactions in Eastern Han Chinese population.
    Xu J; Shi X; Qiu Y; Zhang Y; Chen S; Shi Y; Deng Y
    Seizure; 2019 Feb; 65():25-30. PubMed ID: 30599396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B*15:11 status and carbamazepine-induced severe cutaneous adverse drug reactions in HLA-B*15:02 negative Chinese.
    Wong CSM; Yap DYH; Ip P; Wong WHS; Chua GT; Yeung CK; Chan HHL; Kwok JSY
    Int J Dermatol; 2022 Feb; 61(2):184-190. PubMed ID: 34553372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
    Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
    Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine.
    Nakkam N; Konyoung P; Amornpinyo W; Saksit N; Tiamkao S; Khunarkornsiri U; Khaeso K; Pattanacheewapull O; Jorns TP; Chumworathayi P; Tassaneeyakul W
    Br J Clin Pharmacol; 2022 Feb; 88(2):773-786. PubMed ID: 34350628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HLA Alleles with Antiepileptic Drug-Induced Mild Cutaneous Reactions: A Case-Control Study of a Northeast Han Chinese Population.
    Zhang W; Ye X; Meng H
    Neurol India; 2022; 70(5):2100-2105. PubMed ID: 36352615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of
    Koomdee N; Kloypan C; Jinda P; Rachanakul J; Jantararoungtong T; Sukprasong R; Prommas S; Nuntharadthanaphong N; Puangpetch A; Ershadian M; John S; Biswas M; Sukasem C
    Front Pharmacol; 2022; 13():866903. PubMed ID: 35450046
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of
    John S; Balakrishnan K; Sukasem C; Anand TCV; Canyuk B; Pattharachayakul S
    J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.
    Rattanavipapong W; Koopitakkajorn T; Praditsitthikorn N; Mahasirimongkol S; Teerawattananon Y
    Epilepsia; 2013 Sep; 54(9):1628-38. PubMed ID: 23895569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand.
    Tiamkao S; Jitpimolmard J; Sawanyawisuth K; Jitpimolmard S
    Int J Clin Pharm; 2013 Aug; 35(4):608-12. PubMed ID: 23649893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between HLA-B*15:02 and oxcarbazepine-induced cutaneous adverse reaction: a meta-analysis.
    Liu Y; Yu Y; Nie X; Zhao L; Wang X
    Pharmacogenomics; 2018 Apr; 19(6):547-552. PubMed ID: 29629814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.
    Wu XT; Hu FY; An DM; Yan B; Jiang X; Kwan P; Stefan H; Zhou D
    Epilepsy Behav; 2010 Nov; 19(3):405-8. PubMed ID: 20833111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.
    Hung SI; Chung WH; Jee SH; Chen WC; Chang YT; Lee WR; Hu SL; Wu MT; Chen GS; Wong TW; Hsiao PF; Chen WH; Shih HY; Fang WH; Wei CY; Lou YH; Huang YL; Lin JJ; Chen YT
    Pharmacogenet Genomics; 2006 Apr; 16(4):297-306. PubMed ID: 16538176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S; Boppana P; Toguri J; DeSantis A
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.